Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Researchers' work from University of Queensland focuses on immunization
April 16th, 2008
New investigation results, 'Self-adjuvanting lipopeptide vaccines,' are detailed in a study published in Current Medicinal Chemistry. According to recent research published in the journal Current Medicinal Chemistry, "Despite the important role of adjuvants for vaccine development, relatively few adjuvants have been successfully incorporated into vaccines intended for human administration. This is in part due to the high toxicity associated with many experimental adjuvants." "This lack of choice effectively hinders the ability to produce vaccines against many diseases, or to improve current vaccine formulations. The conjugation of immunostimulatory lipids...
Source: Vaccine Weekly (2008-04-16)
|
